Physician

Naim T. Nazha, M.D.

According to 2025 Medicare claims, Naim Nazha, M.D. (NPI: 1730136854) practices medical oncology in the Atlantic City-Hammonton, NJ market, with the plurality of this provider's patient population coming from Atlantic, NJ. This provider's primary affiliated billing organization is NAIM T. NAZHA MD PC (NPI: 1013908847; TIN: 223424577) and primary practice location at 08225-1648.

Nazha's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 923 traditional Medicare patients, billed 371,208 HCPCS/CPT codes, and received $6,546,337 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,667 prescription claims across 325 beneficiaries totaling $3,938,923 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 37 claims. Open Payments data shows 34 records totaling $891. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,307,118 to $3,938,923. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,267 to $766.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,102	461,121	$5,070,185
2016	1,112	368,401	$5,220,828
2017	1,003	406,701	$4,630,009
2018	993	528,202	$5,899,424
2019	822	448,165	$4,992,863
2020	725	336,051	$4,319,846
2021	703	346,230	$5,524,766
2022	676	309,277	$4,891,045
2023	701	300,675	$4,782,791
2024	923	371,208	$6,546,337

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	311	1,785	$1,307,118
2016	322	1,804	$1,385,897
2017	303	1,821	$1,555,593
2018	331	1,819	$1,720,760
2019	311	1,619	$1,627,088
2020	273	1,424	$1,490,702
2021	281	1,353	$1,811,477
2022	270	1,308	$2,608,897
2023	269	1,315	$2,920,870
2024	325	1,667	$3,938,923

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	25	$2,507
2016	N/R	58	$1,885
2017	N/R	14	$1,077
2018	11	12	$1,055
2019	N/R	N/R	N/R
2020	N/R	15	$508
2021	N/R	93	$59,129
2022	N/R	45	$5,624
2023	N/R	43	$5,802
2024	N/R	37	$4,232

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	804	2,525	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	614	1,299	$76
96372	Injection of drug or substance under skin or into muscle	242	2,041	$12
36415	Insertion of needle into vein for collection of blood sample	895	3,815	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	874	3,759	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	38	1,140	$656,960
Imbruvica	Ibrutinib	37	1,058	$607,701
Revlimid	Lenalidomide	25	700	$498,466
Promacta	Eltrombopag Olamine	22	660	$290,848
Lenalidomide	Lenalidomide	20	560	$288,717

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	11	$1,586
B4035	Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	12	$1,524
B4155	Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	14	$1,122

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	34	$891	SHIELD THERAPEUTICS INC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naim T. Nazha, M.D.?

Tedicare shows public-source Medicare data for Naim T. Nazha, M.D. (NPI 1730136854), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naim T. Nazha, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Naim T. Nazha, M.D.?

Naim T. Nazha, M.D. is linked to NAIM T. NAZHA MD PC (billing NPI 1013908847) in the available physician profile data.

Does Naim T. Nazha, M.D. have Open Payments data?

Naim T. Nazha, M.D. has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.